Skip to content

Ayurvedic Management of Ajeerna (Indigestion).

An open label clinical trial to evaluate the efficacy of Pachmeena Tonic in Ajeerna (Indigestion). - PTI

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022661
Enrollment
50
Registered
2020-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: Pachmeena Tonic: Pachmeena tonic contains Nagarmotha (Cyperus rotundus), Haritaki (Terminalia chebula), Ajawain (Trachyspermum ammi), Maricha (Piper nigrum), Methika (Trigonella foenum-

Sponsors

Multani Pharmaceuticals Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects suffering from Ajeerna (Indigestion) and its related signs and symptoms such as fullness, bloating, nausea, gassy discomfort, loss of appetite, spasm and pain in the chest or abdomen for at least on two occasions in the preceding week and having normal hepatic and renal functions (LFT & RFT).

Exclusion criteria

Exclusion criteria: 1. Subjects with persistent dyspepsia, vomiting, severe epigastric pain unintentional weight loss, iron deficiency anemia, gastro-intestinal bleeding, dysphasia, odynophagia, previous gastric surgery, epigastric mass, suspicious barium meal, peptic ulcer, and NSAID use. 2. Organic deformity or malignancy of the GI tract, significant systemic and psychological condition (s) which may hamper the study proceedings, conditions requiring immediate surgical intervention, Alcohol or drug abuse, pregnancy and lactating women.

Design outcomes

Primary

MeasureTime frame
Improvement in Fullness of StomachTimepoint: 15 Days

Secondary

MeasureTime frame
Improvement in other subjective parametersTimepoint: 30 Days

Countries

India

Contacts

Public ContactDr Bharat Kumar C Padhar

Multani Pharmaceuticals Ltd. New Delhi

dr.hstiwari@multani.org9654350714

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026